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ABSTRACT
Introduction: Cancer treatments have greatly
advanced over the past two decades causing survival
improvements and reduced complications from cancer
surgery. However, the cancer diagnosis and the effects
of treatment modalities pose a major risk to patients’
psychological well-being. Given current interest and
emerging evidence about the importance of
psychological and social factors on cancer survival and
coping with cancer treatments, this study will build and
expand research in order to identify key modifiable
psychosocial variables that contribute to better physical
and mental health following gastrointestinal cancer
(GIC) surgery.
Objectives: To elucidate the incidence of
postoperative psychiatric morbidity within 6 months
following GIC surgery. To identify key measurable
modifiable preoperative psychological factors that can
significantly affect postoperative psychiatric morbidity
in patients undergoing surgery for GIC. To clarify the
changes seen in a patient’s psychological well-being
during their treatment pathway for GIC.
Methods and analysis: This multicentre study has
an observational longitudinal study design. In total,
1000 patients will be screened with a multicomponent
psychological questionnaire at four different time
points: at diagnosis, preoperatively, 1 and 6 months
after surgery. Data from this questionnaire will be
linked to postoperative complications including
psychiatric morbidity, length of hospital stay and
recovery to normal activity.
Ethics and dissemination: NHS Health Research
Authority approval was gained on (REC reference 15.
LO/1847) for the completion of this study. Multiple
platforms will be used for the dissemination of the
research data, including international clinical and
patient group presentations and publication of research
outputs in a high impact clinical journal.
INTRODUCTION
Cancer diagnosis and treatment have a pro-
found effect on patients’ physical and psycho-
logical well-being.1–4 Patients can experience
elevated stress and anxiety levels, depressive
symptomatology, psychosomatic symptoms
and, subsequently, may adopt maladaptive
coping strategies,5–7 leading to poorer cancer
outcomes and survival rates.8–11 Depression
has been linked to increased mortality risk in
patients with lung cancer,11 while convergent
evidence suggests its prevalence among this
group of patients can be as high as 40%.12 In
a national UK study we showed that the rate
of psychiatric morbidity was signiﬁcantly
higher in patients with GIC even after control-
ling for preoperative psychiatric morbidity.
Furthermore, when adjusted for covariates
preoperative psychiatric diagnosis made a
unique and signiﬁcant contribution to long-
term mortality rates following cancer surgery.
Similar effects were observed for post-
operative psychiatric morbidity.1 These ﬁnd-
ings were paralleled in a Swedish cohort
study, which showed new-onset psychiatric
morbidity after oesophagectomy was asso-
ciated with increased mortality.13
The mechanisms by which psychological
variables, such as anxiety and depression,
impact patient cancer outcomes and, espe-
cially, survival are still unclear,12 and under-
investigated. For the relationship between
depression and poor outcomes a number of
speculative explanations have been proposed,
such as psychobiological effects via endocrine
or immunological pathways, ampliﬁed
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depression severity due to symptom seriousness and lack
of compliance with treatment protocol as an outcome of
depression.
In a comprehensive review study, a number of psycho-
logical variables, such as social support, marriage,
emotion constraint as well as depression, have been
linked to breast cancer survival.14 The impact of person-
ality on cancer onset and survival has also attracted sci-
entiﬁc attention. However, methodological limitations
(eg, the use of short questionnaires due to time con-
straints) and failure to control for confounding vari-
ables,12 have hindered the discovery of direct causal
effects between psychosocial variables and cancer onset
and survival. Current evidence is predominantly based
on cross-sectional studies, small sample sizes and exten-
sive variations in psychological parameters and outcome
metrics across studies.14 15 Furthermore, the hypothe-
sised causal associations remain unclear and warrant
further investigation.12 16 17
No study thus far has investigated the patient cancer
trajectory and how different cancer treatment modalities
may have differential impact on patient onset of psychi-
atric morbidity, although some relevant data from diag-
nostic pathways do exist.18 19 Furthermore, the potential
link between psychosocial factors and cancer gave rise to
the development of interventions in order to alleviate
psychological and physical distress and improve sur-
vival.20–23 However, detailed and reliable patient proﬁl-
ing prior to the development of tailored targeted
interventions has been inexplicably overlooked.
Given the current interest and trends in the literature
regarding the importance of person-speciﬁc and
context-speciﬁc variables on cancer survival, our work
will focus on investigating and identifying a wide range
of modiﬁable psychosocial factors that may contribute to
improved psychological and physical outcomes for
patients during their cancer pathway. This comprehen-
sive investigation aims to develop a patient proﬁling tool
that can be used for the early identiﬁcation of patients
at risk of psychiatric morbidity. The tool will allow for
the future development of tailored, targeted interven-
tions before and following cancer treatment in order to
reduce psychiatric morbidity and adverse cancer out-
comes including mortality.
The importance of this study lies in the inclusion of
an under-researched population (ie, patients with GIC),
comprising patients who are likely to suffer life-altering
effects as a result of their cancer treatment. Patients
undergoing GIC surgery represent a unique patient
group, as surgery fundamentally impacts several aspects
of normal daily life including eating, bowel function,
pain and levels of fatigue, with often prolonged effects
on quality of life.24 25 The problem is heightened by the
greater incidence of postoperative complications seen in
GIC surgery compared to other studied types of
surgery.24 25 Also, to the best of our knowledge, this is
the ﬁrst prospective study to examine a number of
potentially modiﬁable factors that clinicians and allied
health professionals can use within the context of a
cancer clinic in order to identify and proﬁle their
patients with the aim of providing targeted support. For
these reasons, this project shares important clinical and
public health implications.
OBJECTIVES
1. To elucidate the incidence of postoperative psychi-
atric morbidity within 6 months following GIC
surgery.
2. To identify key measurable modiﬁable preoperative
psychological factors that can signiﬁcantly affect post-
operative psychiatric morbidity in patients undergo-
ing surgery for GIC.
3. To clarify the changes seen in a patient’s psycho-
logical well-being during their treatment pathway for
GIC.
METHODS AND ANALYSIS
Study design
This is a longitudinal study that will use a multifactorial
psychological questionnaire (see online supplementary
appendix A) to be administered at different time points
in the patient treatment pathway (ﬁgure 1). Key factors
from this questionnaire will be identiﬁed through correl-
ation with outcomes of postoperative recovery in particu-
lar psychiatric morbidity.
Patient pathway and recruitment
Participants will be approached for recruitment after
their consultation at a cancer or surgical clinic. The
questionnaire will be completed individually. Testing ses-
sions conducted by a research psychologist are expected
to last ∼25 min. Patients’ emotional perceptions (‘trait
emotional intelligence’), coping, emotion regulation,
anxiety and depression will be tested via the question-
naire. Information regarding participants’ recovery out-
comes and survival will be obtained from the medical
records including postoperative complications and
length of hospital stay. Patients will be screened typically
four or ﬁve times along their patient pathway (ﬁgure 1);
prior to any treatment, following neoadjuvant chemo-
therapy or chemoradiotherapy (if received), 1, 6 and
12 months following primary surgical resection of the
GIC. Some patients with colorectal cancer may receive
a defunctioning ileostomy at the time of GIC resection;
however, this is most commonly reversed within
12 months of surgery and thus psychological screening
will be performed in the presence and absence of
a stoma.
Patients will be recruited from centres across Europe.
Measures
Archival data
Demographic information: Data on patient gender, age,
body mass index, ethnic background, socioeconomic
status (Carstairs index), smoking status, medical
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comorbidities, GIC type (oesophageal, gastric or colorec-
tal) and previous psychiatric diagnosis will be collected
through review of medical records.
Tumour and treatment information: Information on stage,
tumour location, type of surgery (including stoma for-
mation) and neoadjuvant therapy used will be collected
by reviewing medical records.
Multifactorial psychological questionnaire
Development of questionnaire
All factors chosen for inclusion were selected as they
have previously been shown to relate to psychological
and/or physical well-being and these are also potentially
modiﬁable psychological variables. Following an initial
literature review, a consensus process and discussion was
used to gain agreement from all authors and collabora-
tors regarding the constructs included within the ques-
tionnaire. The questionnaire was then piloted in ﬁve
patients, with feedback received and further modiﬁca-
tion of the questionnaire performed to generate the
ﬁnal questionnaire for use in the study (see online
supplementary appendix A).
Psychological factors included in questionnaire
Trait Emotional Intelligence: The Trait Emotional
Intelligence Questionnaire-Short Form (TEIQue-SF)26
comprises 30 items responded to a seven-point Likert
scale. The instrument provides scores on well-being, self-
control, emotionality, sociability and global trait emo-
tional intelligence.
Beck Depression Inventory (BDI-II).27 The BDI-II com-
prises 21 items assessing the severity of depression. Each
item presents a list of four statements about a particular
symptom of depression, arranged in increasing severity.
A total score is calculated, with 0–13 indicating minimal
depression, 14–19 indicating mild depression, 20–28
indicating moderate depression and 29–63 indicating
severe depression. The BDI has been used to assess
depression for over 40 years,28 and has strong evidence
of reliability and validity.
BRIEF-COPE.29 This is a 28-item questionnaire
designed to assess 14 conceptually distinct methods of
coping (active coping, self-distraction, denial, substance
use, use of emotional support, use of instrumental
support, venting, positive reframing planning, humour,
acceptance, religion and self-blame). It is an abbreviated
version of the COPE questionnaire and it has good psy-
chometric properties.
State-Trait Anxiety Inventory (STAI)–Short Form.30 The
STAI assesses an individual’s conscious awareness at two
extremes of anxiety affect, labelled state anxiety
(A-state), and trait anxiety (A-trait), respectively. A-Trait
can be deﬁned as a relatively enduring disposition to
feel stress, worry and discomfort and this is what we are
measuring for the purposes of this study (20 items). The
questionnaire has robust psychometric properties, and
has been widely used across different populations.31
Expectancy-Value Questionnaire. This brief measure
assesses health-related self-efﬁcacy as well as health-
related values. It is based on belief-importance theory,32
which has shown exceptionally strong predictive utility
achieved through brief, unobtrusive and easily adminis-
trable instruments.
Outcome data
The primary outcome for this study is postoperative psy-
chiatric morbidity within 30 days of surgery. Secondary
outcomes for this study include, completion of intended
neoadjuvant therapy, admission to hospital during
neoadjuvant therapy, length of hospital stay following
surgery, postoperative complications and recovery to
normal activity in the community (SF-36) (assessed at
the same time points as psychological questionnaire
ﬁgure 1). SF-36 was chosen to permit comparison
between different GICs. Standardised deﬁnition of com-
plications will be used for the study to allow meaningful
comparison of complications including psychiatric
morbidity.33
SYMPTOMATIC QUALITY OF LIFE QUESTIONNAIRE
At the same time points as the psychological screening,
patients will be asked to complete symptomatic quality
of life questionnaires related to their primary diagnosis.
For patients with colorectal cancer this will be the
EORTC QLQ-CR29,34 for patients with oesophageal
cancer this will be EORTC QLQ-OES24,35 and for
patients with gastric cancer this will be EORTC
QLQ-STO 22.36
Figure 1 Patient pathway and
timing of psychological screening
test.
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INCLUSION CRITERIA
Patients undergoing intended curative surgery for the
management of GIC.
EXCLUSION CRITERIA
1. Patients with metastatic GIC.
2. Patients undergoing non-curative surgery or no surgi-
cal intervention for GIC.
3. Patients undergoing surgery for a benign condition
of the gastrointestinal tract.
Sample size
Based on the number of predictors (k) in the logistic
regression model and predicted prevalence rate of post-
operative psychiatric morbidity (p). Then:
Sample size (n) ¼ 10 k=p
With 9 covariates and a predicted prevalence rate of
postoperative psychiatric morbidity of 12%, the sample
size required will be 750 patients.
We anticipate running patient recruitment for
10 months with a further 6 months follow-up. From the
national audit ﬁgures for colorectal and oesophagogastric
cancer, on average each participating European centre
performs 18 GIC surgical resections per month; therefore,
over the 10-month recruitment period 180 patients per
centre will be screened. Eight centres will participate in
the study giving an expected recruitment of 1440 patients;
the expected dropout rate during the follow-up period is
25%. Taking attrition into consideration the expected
actual recruitment for the study will be 1080 patients.
Statistical methodology
Descriptive and exploratory analysis of statistics will be
conducted to check the suitability of the data for infer-
ential statistics. Scoring from the questionnaire will be
analysed at different time points to observe changes in
patients’ psychological well-being during the course of
their cancer treatment using linear mixed-effect models.
Comparison across changes observed in each psycho-
logical area will be examined, in association with each
time-point in the patient-treatment pathway using linear
mixed-effect models.
Comparison of preoperative psychological factors from
the questionnaire between patients with and without post-
operative psychiatric morbidity will also be performed.
Multivariable regression analysis will be employed to
regress for the effect of patient and tumour-related
factors, surgical or medical complications on postoperative
psychiatric morbidity. Key preoperative psychological
factors associated with postoperative psychiatric morbidity
will be identiﬁed by regression analysis.
Dissemination
Different methods of dissemination will be employed so
that the ﬁndings from this research will reach patients,
primary care practitioners, scientists, hospital specialists
in gastroenterology, oncology and surgery, health policy-
makers and commissioners as well as healthcare regula-
tory bodies. The study ﬁndings will be presented at
international gastroenterology, oncology and surgical
research meetings. The ﬁndings of this research will also
be presented to relevant patient groups. Ultimately, we
plan to publish the results of this research in a high
impact clinical journal to allow widespread dissemin-
ation of this research.
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